90 related articles for article (PubMed ID: 9379040)
1. T cell receptor-mediated signaling is defective in T cells obtained from patients with primary intracranial tumors.
Morford LA; Elliott LH; Carlson SL; Brooks WH; Roszman TL
J Immunol; 1997 Nov; 159(9):4415-25. PubMed ID: 9379040
[TBL] [Abstract][Full Text] [Related]
2. Conversion of p56(lck) to p60(lck) in human peripheral blood T lymphocytes is dependent on co- stimulation through accessory receptors: involvement of phospholipase C, protein kinase C and MAP-kinases in vivo.
Schröder AJ; Quehl P; Müller J; Samstag Y
Eur J Immunol; 2000 Feb; 30(2):635-43. PubMed ID: 10671221
[TBL] [Abstract][Full Text] [Related]
3. Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma.
Lai P; Rabinowich H; Crowley-Nowick PA; Bell MC; Mantovani G; Whiteside TL
Clin Cancer Res; 1996 Jan; 2(1):161-73. PubMed ID: 9816103
[TBL] [Abstract][Full Text] [Related]
4. Chronic PMA treatment of Jurkat T lymphocytes results in decreased protein tyrosine phosphorylation and inhibition of CD3- but not Ti-dependent antibody-triggered Ca2+ signaling.
Ahnadi CE; Giguère P; Gravel S; Gagné D; Goulet AC; Fülöp T; Payet MD; Dupuis G
J Leukoc Biol; 2000 Aug; 68(2):293-300. PubMed ID: 10947075
[TBL] [Abstract][Full Text] [Related]
5. Protein tyrosine phosphatase CD148-mediated inhibition of T-cell receptor signal transduction is associated with reduced LAT and phospholipase Cgamma1 phosphorylation.
Baker JE; Majeti R; Tangye SG; Weiss A
Mol Cell Biol; 2001 Apr; 21(7):2393-403. PubMed ID: 11259588
[TBL] [Abstract][Full Text] [Related]
6. Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy.
Bukowski RM; Rayman P; Uzzo R; Bloom T; Sandstrom K; Peereboom D; Olencki T; Budd GT; McLain D; Elson P; Novick A; Finke JH
Clin Cancer Res; 1998 Oct; 4(10):2337-47. PubMed ID: 9796963
[TBL] [Abstract][Full Text] [Related]
7. A CD28-associated signaling pathway leading to cytokine gene transcription and T cell proliferation without TCR engagement.
Siefken R; Klein-Hessling S; Serfling E; Kurrle R; Schwinzer R
J Immunol; 1998 Aug; 161(4):1645-51. PubMed ID: 9712026
[TBL] [Abstract][Full Text] [Related]
8. Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus.
Nambiar MP; Fisher CU; Warke VG; Krishnan S; Mitchell JP; Delaney N; Tsokos GC
Arthritis Rheum; 2003 Jul; 48(7):1948-55. PubMed ID: 12847689
[TBL] [Abstract][Full Text] [Related]
9. Defective TCR-mediated signaling in synovial T cells in rheumatoid arthritis.
Maurice MM; Lankester AC; Bezemer AC; Geertsma MF; Tak PP; Breedveld FC; van Lier RA; Verweij CL
J Immunol; 1997 Sep; 159(6):2973-8. PubMed ID: 9300721
[TBL] [Abstract][Full Text] [Related]
10. Activation of naïve CD4 T cells by anti-CD3 reveals an important role for Fyn in Lck-mediated signaling.
Sugie K; Jeon MS; Grey HM
Proc Natl Acad Sci U S A; 2004 Oct; 101(41):14859-64. PubMed ID: 15465914
[TBL] [Abstract][Full Text] [Related]
11. Expression and activity of signaling molecules in T lymphocytes obtained from patients with metastatic melanoma before and after interleukin 2 therapy.
Rabinowich H; Banks M; Reichert TE; Logan TF; Kirkwood JM; Whiteside TL
Clin Cancer Res; 1996 Aug; 2(8):1263-74. PubMed ID: 9816296
[TBL] [Abstract][Full Text] [Related]
12. Bacterial superantigens bypass Lck-dependent T cell receptor signaling by activating a Galpha11-dependent, PLC-beta-mediated pathway.
Bueno C; Lemke CD; Criado G; Baroja ML; Ferguson SS; Rahman AK; Tsoukas CD; McCormick JK; Madrenas J
Immunity; 2006 Jul; 25(1):67-78. PubMed ID: 16860758
[TBL] [Abstract][Full Text] [Related]
13. Inefficient phospholipase C activation and reduced Lck expression characterize the signaling defect of umbilical cord T lymphocytes.
Miscia S; Di Baldassarre A; Sabatino G; Bonvini E; Rana RA; Vitale M; Di Valerio V; Manzoli FA
J Immunol; 1999 Sep; 163(5):2416-24. PubMed ID: 10452976
[TBL] [Abstract][Full Text] [Related]
14. Sequestration of CD4-associated Lck from the TCR complex may elicit T cell hyporesponsiveness in nonobese diabetic mice.
Zhang J; Salojin K; Delovitch TL
J Immunol; 1998 Feb; 160(3):1148-57. PubMed ID: 9570528
[TBL] [Abstract][Full Text] [Related]
15. The Src-homology domain 2-bearing protein tyrosine phosphatase-1 inhibits antigen receptor-induced apoptosis of activated peripheral T cells.
Zhang J; Somani AK; Watt S; Mills GB; Siminovitch KA
J Immunol; 1999 Jun; 162(11):6359-67. PubMed ID: 10352248
[TBL] [Abstract][Full Text] [Related]
16. Sustained T cell receptor-mediated Ca2+ responses rely on dynamic engagement of receptors.
Hashemi BB; Slattery JP; Holowka D; Baird B
J Immunol; 1996 May; 156(10):3660-7. PubMed ID: 8621900
[TBL] [Abstract][Full Text] [Related]
17. Cytokinetic basis for the impaired activation of lymphocytes from patients with primary intracranial tumors.
Elliott LH; Brooks WH; Roszman TL
J Immunol; 1984 Mar; 132(3):1208-15. PubMed ID: 6319491
[TBL] [Abstract][Full Text] [Related]
18. [Clinicoimmunological values of measurement of IgG-Fc receptor positive T cells in the patients with malignant brain tumors].
Yoshida S; Hara N; Takai N; Saito T; Tanaka R
No To Shinkei; 1985 Nov; 37(11):1073-8. PubMed ID: 2934080
[TBL] [Abstract][Full Text] [Related]
19. In vitro analysis of the proliferative potential of T cells from patients with brain tumor: glioma-associated immunosuppression unrelated to intrinsic cellular defect.
McVicar DW; Davis DF; Merchant RE
J Neurosurg; 1992 Feb; 76(2):251-60. PubMed ID: 1730954
[TBL] [Abstract][Full Text] [Related]
20. Capacity of sera from patients with primary intracranial tumors to support mitogen stimulation of blood lymphocytes. Correlation to histological tumor type.
Blomgren H; Blom U; Ullén H
Anticancer Res; 1985; 5(4):349-54. PubMed ID: 4037733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
